Trazimera

Trazimera (trastuzumab) is a targeted therapy used in cancer treatment. It belongs to the monoclonal antibody class and is administered intravenously. This medication is prescribed for specific types of breast and stomach cancers.

Trazimera (trastuzumab) is used to treat certain types of breast cancer and stomach cancer. It works by targeting cancer cells that overexpress the HER2 protein, helping to slow or stop their growth. This medication is often used in combination with other cancer therapies. Patients may ask, 'what is Trazimera used for' to understand its role in treatment.

Trazimera (trastuzumab) may cause side effects such as fever, chills, nausea, or headache during or after infusion. Some patients experience fatigue or weakness. These effects are typically temporary and monitored by healthcare providers to ensure safety and comfort.

Trazimera (trastuzumab) requires careful handling and administration under medical supervision. Patients should inform their healthcare provider about any allergies, infections, or heart conditions before starting treatment. Regular monitoring of heart function may be necessary during therapy.

Trazimera (trastuzumab) may interact with other medications, including chemotherapy drugs and certain heart medications. Patients should discuss all current medications with their healthcare provider to avoid potential interactions. Alcohol use may not be recommended during treatment.